Protective effect of vitamin E against diabetes-induced oxidized LDL and aorta cell wall proliferation in rat

Iranian Biomedical Journal

Volumn 19, Issue 2, 2015, Pages 117-123

  Shirpoor, Alireza ^a   Norouzi, Leila ^a   Nemati, Samira ^a   Khadem Ansari, Mohammad Hasan ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Ox LDL; Vitamin E; VSMC proliferation

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN A; C REACTIVE PROTEIN; CYCLINE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; PLACEBO; TRIACYLGLYCEROL; ANTIOXIDANT; LIPID; LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIARRHEAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL WALL; CELLULAR DISTRIBUTION; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC CARDIOMYOPATHY; DOWN REGULATION; DRUG MECHANISM; DRUG TARGETING; GLYCEMIC CONTROL; HEART PROTECTION; HEMOGLOBIN BLOOD LEVEL; INFLAMMATION; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPOLYSIS; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RAT MODEL; SHAM PROCEDURE; SMOOTH MUSCLE FIBER; TISSUE DISTRIBUTION; UPREGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; AORTA; BLOOD; CARDIOVASCULAR DISEASES; CYTOLOGY; HYPERLIPIDEMIA; METABOLISM; PATHOLOGY; PHYSIOLOGY; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; ANTIOXIDANTS; AORTA; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CELL PROLIFERATION; DIABETES MELLITUS; HYPERLIPIDEMIAS; LIPIDS; LIPOPROTEINS, LDL; MALE; MUSCLE, SMOOTH, VASCULAR; OXIDATIVE STRESS; RATS; RATS, WISTAR; VITAMIN E;

EID: 84924694368     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: 10.6091/ibj.1449.2015     Document Type: Article

References (38)

1. Marks JB, Raskin P. Cardiovascular risk in diabetes: a brief review. J Diabetes Complications. 2000 Mar-Apr; 14 (2):108-15.
2. Hamed S, Brenner B, Abassi Z, Aharon A, Daoud D, Roguin A. Hyperglycemia and oxidized-LDL exert a deleterious effect on endothelial progenitor cell migration in type 2 diabetes mellitus. Thromb Res. 2010 Sep; 126(3):166-74.
3. Inoue M, Itoh H, Tanaka T, Chun TH, Doi K, Fukunaga Y, et al. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscler Thromb Vasc Biol. 2001 Apr; 21(4):560-6.
4. Higashi Y, Peng T, Du J, Sukhanov S, Li Y, Itabe H, et al. A redox-sensitive pathway mediates oxidized LDL-induced downregulation of insulin-like growth factor-1 receptor. J Lipid Res. 2005 Jun; 46(6):1266-77.
5. Zeller T, Wild P, Szymczak S, Rotival M, Schillert A, Castagne R, et al. Genetics and beyond--the transcriptome of human monocytes and disease susceptibility. PLoS One. May 2010; 5(5):e10693.
6. Tamada K, Shimozaki K, Chapoval AI, Zhai Y, Su J, Chen SF, et al. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol. 2000 Apr; 15;164(8):4105-10.
7. Higashi Y, Peng T, Du J, Sukhanov S, Li Y, Itabe H, et al. A redox-sensitive pathway mediates oxidized LDL-induced downregulation of insulin-like growth factor-1 receptor. J Lipid Res. 2005 Jun; 46(6):1266-77.
8. Hulthe J, Fagerberg B. Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study). Arterioscler Thromb Vasc Biol. 2002 Jul; 22(7):1162-7.
9. Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Butler SW, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA. 1989 Feb; 86(4):1372-6.
10. Pasceri V, Wu HD, Willerson JT,Yeh ET. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators. Circulation. 2000 Jan; 5;101(3):235-8.
11. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997 Apr; 336(14):973-9.
12. Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P, et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation. 2003 Apr; 107(13):1783-90.
13. Zwaka TP, Hombach V, Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation. 2001 Mar; 103(9):1194-7.
14. Peng N, Liu JT, Gao DF, Lin R, Li R. Angiotensin II-induced C-reactive protein generation: inflammatory role of vascular smooth muscle cells in atherosclerosis. Atherosclerosis. 2007 Aug; 193(2):292-8.
15. Guo F, Liu J, Wang C, Liu N, Lu P. Fibrinogen, fibrin, and FDP induce C-reactive protein generation in rat vascular smooth muscle cells: pro-inflammatory effect on atherosclerosis. Biochem Biophys Res Commun. 2009 Dec; 390(3):942-6.
16. Guo F, Liu J, Wang C, Liu N, Lu P. Fibrinogen, fibrin, and FDP induce C-reactive protein generation in rat vascular smooth muscle cells: pro-inflammatory effect on atherosclerosis. Biochem Biophys Res Commun. 2009 Dec; 390(3):942-6.
17. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Jr., Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994 May; 89(5):2462-78.
18. Bjorkerud B, Bjorkerud S. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscler Thromb Vasc Biol. 1996 Mar; 16(3):416-24.
19. Watanabe T, Pakala R, Katagiri T, Benedict CR. Mildly oxidized low-density lipoprotein acts synergistically with angiotensin II in inducing vascular smooth muscle cell proliferation. J Hypertens. 2001 Jun; 19(6):1065-73.
20. Shirpoor A, Salami S, Khadem-Ansari MH, Ilkhanizadeh B, Pakdel FG, Khademvatani K. Cardioprotective effect of vitamin E: rescues of diabetes-induced cardiac malfunction, oxidative stress, and apoptosis in rat. J Diabetes Complications. 2009 Sep-Oct; 23(5):310-6.
21. Tayama J, Munakata M, Yoshinaga K,Toyota T. Higher plasma homocysteine concentration is associated with more advanced systemic arterial stiffness and greater blood pressure response to stress in hypertensive patients. Hypertens Res. 2006 Jun; 29(6):403-9.
22. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001 Dec; 414 (6865):813-20.
23. Sharma M, Rai SK, Tiwari M, Chandra R. Effect of hyperhomocysteinemia on cardiovascular risk factors and initiation of atherosclerosis in Wistar rats. Eur J Pharmacol. 2007 Nov; 574(1):49-60.
24. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res. 1999 Oct; 85(8):753-66.
25. Pope KO, Pohl ME, Jones JG, Lentz DL, von Nagy C, Vega FJ, et al. Origin and environmental setting of ancient agriculture in the lowlands of Mesoamerica. Science; 2001 May; 292(5520):1370-3.
26. Scott-Burden T, Resink TJ, Hahn AW, Baur U, Box RJ, Buhler FR. Induction of growth-related metabolism in human vascular smooth muscle cells by low density lipoprotein. J Biol Chem. 1989 Jul; 264(21):12582-9.
27. Natarajan V, Scribner WM, Hart CM, Parthasarathy S. Oxidized low density lipoprotein-mediated activation of phospholipase D in smooth muscle cells: a possible role in cell proliferation and atherogenesis. J Lipid Res. 1995 Sep; 36(9):2005-16.
28. Galle J, Schneider R, Heinloth A, Wanner C, Galle PR, Conzelmann E, et al. Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress. Kidney Int. 1999 Apr; 55(4):1450-61.
29. Lamharzi N, Renard CB, Kramer F, Pennathur S, Heinecke JW, Chait A, et al. Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL. Diabetes. 2004 Dec; 53(12): 3217-25.
30. Kanter JE, Johansson F, LeBoeuf RC, Bornfeldt KE. Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? Circ Res. 2007 Mar; 100 (6):769-81.
31. Assmann G, Cullen P,Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation. 2002 Jan; 105(3):310-5.
32. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006 Jan; 97(2A):3A-11A.
33. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, et al. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. J Cardiol. 1999 Feb; 33(2):105-6.
34. Walldius G, Jungner I. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy-a review of the evidence. J Intern Med. 2006 May; 259(5):493-519.
35. Thompson SG, Kienast J, Pyke SD, Haverkate F,van de Loo C. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 1995 Mar; 332(10):635-41.
36. Haidara MA, Mikhailidis DP, Rateb MA, Ahmed ZA, Yassin HZ, Ibrahim IM, et al. Evaluation of the effect of oxidative stress and vitamin E supplementation on renal function in rats with streptozotocin-induced Type 1 diabetes. J Diabetes Complications. 2009 Mar-Apr; 23(2):130-6.
37. Devaraj S, Leonard S, Traber MG, Jialal I. Gamma-tocopherol supplementation alone and in combination with alpha-tocopherol alters biomarkers of oxidative stress and inflammation in subjects with metabolic syndrome. Free Radic Biol Med. 2008 Mar; 44(6): 1203-8.
38. Servais S, Letexier D, Favier R, Duchamp C, Desplanches D. Prevention of unloading-induced atrophy by vitamin E supplementation: links between oxidative stress and soleus muscle proteolysis? Free Radic Biol Med. 2007 Mar; 42(5):627-35.